Mirion Technologies (NYSE:MIR – Get Free Report) is one of 377 publicly-traded companies in the “Electronic Equipment, Instruments & Components” industry, but how does it contrast to its rivals? We will compare Mirion Technologies to similar companies based on the strength of its dividends, valuation, earnings, profitability, institutional ownership, analyst recommendations and risk.
Profitability
This table compares Mirion Technologies and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Mirion Technologies | 2.39% | 6.59% | 3.53% |
| Mirion Technologies Competitors | -167.85% | -25.41% | -6.86% |
Valuation and Earnings
This table compares Mirion Technologies and its rivals top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Mirion Technologies | $1.02 billion | $28.80 million | 185.64 |
| Mirion Technologies Competitors | $115.44 billion | $167.44 million | 0.90 |
Mirion Technologies’ rivals have higher revenue and earnings than Mirion Technologies. Mirion Technologies is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.
Volatility and Risk
Mirion Technologies has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500. Comparatively, Mirion Technologies’ rivals have a beta of -0.17, indicating that their average stock price is 117% less volatile than the S&P 500.
Insider and Institutional Ownership
78.5% of Mirion Technologies shares are held by institutional investors. Comparatively, 43.3% of shares of all “Electronic Equipment, Instruments & Components” companies are held by institutional investors. 2.2% of Mirion Technologies shares are held by company insiders. Comparatively, 16.6% of shares of all “Electronic Equipment, Instruments & Components” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Analyst Recommendations
This is a summary of recent recommendations for Mirion Technologies and its rivals, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Mirion Technologies | 0 | 2 | 7 | 1 | 2.90 |
| Mirion Technologies Competitors | 2046 | 7582 | 10382 | 650 | 2.47 |
Mirion Technologies currently has a consensus price target of $25.12, indicating a potential upside of 35.34%. As a group, “Electronic Equipment, Instruments & Components” companies have a potential upside of 31.39%. Given Mirion Technologies’ stronger consensus rating and higher possible upside, equities research analysts plainly believe Mirion Technologies is more favorable than its rivals.
Summary
Mirion Technologies beats its rivals on 10 of the 13 factors compared.
About Mirion Technologies
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products. This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation. The Technologies segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. The company was incorporated in 2005 and is headquartered in Atlanta, Georgia.
Receive News & Ratings for Mirion Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mirion Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
